Search
FDA Embraces AI Technology to Streamline Drug Approval Process
2025-05-12 /
Read about 0 minute
Author：小编
The Food and Drug Administration (FDA) has announced the full integration of AI technology across all its centers by June 30, aiming to expedite the drug approval process. This initiative is anticipated to significantly cut down approval times by alleviating the burden of repetitive tasks on reviewers and boosting overall efficiency. The FDA Commissioner has expressed great optimism about AI, hailing it as a "game-changer" in the realm of drug regulation. Nevertheless, the application of AI in the medical field has also raised concerns within the industry, particularly regarding the risks of misleading information.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
